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Abstract 
Extrahepatic cells, especially bone marrow cells, might contribute to liver repair but not 
in the normally regenerating liver according to the recent updated literature. The 
mechanism by which extrahepatic cells express a liver-specific function in a liver, 
whether transdifferentiation or cell fusion, remains under debate. In this review, we 
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Introduction 
It has been reported that extrahepatic cells, especially bone marrow-derived cells, are 
mobilized and involved in liver tissue repair, including that after injury.1-17 However, 
details regarding how extrahepatic cells are involved and how much they contribute to 
normal liver regeneration have not been fully elucidated. Even if such involvement is 
present, it remains unclear whether liver-specific function is achieved through 
transdifferentiation or cell fusion. In this review, we investigate the status of findings on 
this matter, and summarize the recent research. 
 
Contribution of extrahepatic cell on liver regeneration or injury 
After partial hepatectomy, liver usually restores its mass within 1-2 weeks 
in rats and 1-3 months in human in order to catch up liver specific function. DNA 
synthesis and cell division of hepatocytes occurs followed by those of non-parenchymal 
cells18, 19. It has long been believed that only cells in a liver participate in such 
restoration. However, after new findings in liver transplant recipients who previously 
underwent bone marrow transplantation, many reports have been focusing on the 
contribution of bone marrow cells to liver repopulation, especially in liver regeneration 
after liver damage or partial hepatectomy, but with controversy (Table. 1,2).  
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In an in vivo experiment conducted in 2000, it was first reported that 
hepatocytes could be derived from bone marrow cells after irradiation in the absence of 
severe acute injury.1 Subsequently, Baccarani et al in 20012 reported that, in human 
recipients, replacement of a female liver venous endothelium with male bone marrow 
showed the possibility of involvement of BM cells in liver rearrangement (Fig. 1) 
followed by Körbling et al.’s finding of the differentiation of circulating stem cells into 
mature hepatocytes.3  From 2002 on, research on this matter has advanced because of 
the advent of green fluorescent protein (GFP) transgenic mice, which expresses green 
fluorescent protein throughout their bodies. The GFP-positive cell-transplant model 
allows researchers to detect transplanted or mobilized cells without complicated 
molecular biological methods. Using this model after GFP-positive bone marrow (BM) 
transplantation, Fujii et al. reported that BM cells participated in liver regeneration after 
hepatectomy, whereas the majority was committed to sinusoidal endothelial cells, 
probably through endothelial progenitor cell mobilization. 4,5  In 2003, Terai et al., 
using their GFP/carbon-tetrachloride (CCl4) mouse model, reported that autologous BM 
cells were an effective treatment for liver failure under persistent liver damage; they 
found the same results for liver cirrhosis.6,7  In 2005, am Esch JS 2nd also reported that 
CD133 (used as hematopoietic stem cell marker) (+) BM stem cells infused into the 
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portal vein accelerated hepatic regeneration.8  Very recently, Conzelmann et al., using 
their reduced-size liver transplantation model, reported that recipient-derived progenitor 
cells were present and might contribute to liver regeneration in mice.9  All these reports 
constitute encouraging data to support the notion that extrahepatic cells, and especially 
BM cells, are potent therapeutic resources for impaired liver regeneration. In addition, 
the studies of partial hepatectomy using rats in which liver regeneration was impaired 
by retrorsine showed some positive results on the matter.10,11 
However, there is still controversy regarding how much involvement is present 
and how the cells are involved. We next turn to the studies regarding this matter (Table 
3). In 2005 Di Campli et al. reported no evidence of hematopoietic stem cell 
mobilization in patients who underwent hepatectomy or in patients with acute liver 
failure. They observed no CD34-positive cells in the blood after hepatectomy for acute 
decompensation of a cirrhotic liver.12 Similarly, in 2006, Moritoki et al., using GFP 
transgenic mice, demonstrated that BM cell transfer seemed not to contribute to the 
differentiation of cholangiocytes in a chronic cholestasis model. They also found 
scattered GFP-positive cells in the hepatic parenchyma.13 In 2007, Tomiyama reported 
the limited contribution of cells originating from intact extrahepatic tissue in hepatocyte 
regeneration in transplanted rat livers. They reported that, even in the non-injured liver, 
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GFP-positive hepatocytes increased by 0.0048% per week, that is, 5×103 were 
generated per day. However, liver injury did not increase the percentage of 
GFP-positive hepatocytes in their liver transplantation model14, as Popp reported similar 
findings in 2007.15 
Taken together, at present, it seems that limited involvement is possible in 
normal liver regeneration after partial hepatectomy. However, in the case of impaired 
liver regeneration, involvement of BM cells may be possible through evidence from an 
in vivo liver injury model. Investigation on liver regeneration using specific model, in 
which liver cells can not perform cell division using retrorsine, showed that no 
contribution of multipotent mesenchymal stromal cells in liver regeneration. Whether 
extrahepatic cells migrated to the regenerating liver function as liver cells or how long 
they can survive are still under debate and varies among previous reports. Nevertheless, 
clinical studies have started with autologous bone marrow cells or CD34+ cells to treat 
liver insufficiency, resulting in moderate effect.18,19 
 
Transdifferentiation or Cell fusion 
It has been intensely debated whether the mechanism by which bone marrow 
cells become hepatocytes is transdifferentiation or fusion.  
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In 2004, Lee et al. reported differentiation of human mesenchymal stem cells 
into hepatocytes in vitro.20 In the transdifferentiation theory, it has been held that the 
phenotype of bone marrow cells changes to that of hepatocytes through coordinated 
changes in the transcriptional activities of many genes. The mesenchymal stem cell 
component in bone marrow cells or other specific stem cells are candidates for this 
ability of transdifferentiation. Also, although transdifferentiation of the peripheral blood 
monocyte-derived subset into hepatic transdifferentiated cells has been reported, the 
question of which cells are involved in the transdifferentiation has not been answered. 
Using their mouse model, Brulport reported evidence not for transdifferentiation but 
instead for a complex situation including partial differentiation and possible horizontal 
gene transfer.21 In 2005, Wu also reported minimal evidence of transdifferentiation from 
recipient bone marrow to parenchymal cells regenerating and long-surviving human 
allografts.22 
On the other hand, “cell fusion” between bone-marrow stem cells and hepatocytes 
was reported and has been believed to be a main mechanism based on an experiment, 
repeated by many researchers, in which new hepatocytes appear after infusion of bone 
marrow cells. 23-27  
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At present, we still do not know the reason why hepatocytes cannot be more 
effectively produced through either the “transdifferentiation” or “fusion” mechanism. 
Those questions and controversies await further research on liver regenerative 
medicine28 
 
In conclusion, to date in the recent literature, extrahepatic cells, especially BM cells, 
might contribute to injured liver repair but not in the normally regenerating liver. The 
mechanism by which extrahepatic cells express a liver-specific function, whether 
transdifferentiation or cell fusion, remains under debate. 
 
Search Strategy 
Recent data for this review were collected by PubMed searches. 
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Transplanted bone marrow cells participated in liver regeneration after partial 
hepatectomy in rats. The majority was committed to sinusoidal endothelial cells. 
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